The glycocalyx, a novel key in understanding of mechanism of diabetic nephropathy: a commentary

[1] Habib AA(2010)Therapeutic strategies for diabetic neuropathy Curr Neurol Neurosci Rep 10 92-100

[2] Brannagan TH(2011)Targeted therapies in diabetic nephropathy: an update J Nephrol 24 686-695

[3] Gupta A(2013)Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms Eur J Pharmacol 719 180-6

[4] Gupta P(2018)Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases Arterioscler Thromb Vasc Biol 38 1427-1439

[5] Biyani M(2020)Inflammatory targets in diabetic nephropathy J Clin Med 9 458-14

[6] Sytze Van Dam P(2010)Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 4-4402

[7] Cotter MA(2016)Emerging therapeutics for the treatment of diabetic nephropathy Bioorg Med Chem Lett 26 4394-8

[8] Bravenboer B(2013)Suppression of XBP1S mediates high glucose-induced oxidative stress and extracellular matrix synthesis in renal mesangial cell and kidney of diabetic rats PLoS One 8 e56124-11

[9] Cameron NE(2017)Pimpinella anisum L. ethanolic extract ameliorates the gentamicin-induced nephrotoxicity in rats Nephrology. 22 133-1075

[10] Dogné S(2016)Glycocalyx and its involvement in clinical pathophysiologies J Intensive Care 4 1-179

[1] Habib AA(2010)Therapeutic strategies for diabetic neuropathy Curr Neurol Neurosci Rep 10 92-100

[2] Brannagan TH(2011)Targeted therapies in diabetic nephropathy: an update J Nephrol 24 686-695

[3] Gupta A(2013)Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms Eur J Pharmacol 719 180-6

[4] Gupta P(2018)Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases Arterioscler Thromb Vasc Biol 38 1427-1439

[5] Biyani M(2020)Inflammatory targets in diabetic nephropathy J Clin Med 9 458-14

[6] Sytze Van Dam P(2010)Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Res Clin Pract 87 4-4402

[7] Cotter MA(2016)Emerging therapeutics for the treatment of diabetic nephropathy Bioorg Med Chem Lett 26 4394-8

[8] Bravenboer B(2013)Suppression of XBP1S mediates high glucose-induced oxidative stress and extracellular matrix synthesis in renal mesangial cell and kidney of diabetic rats PLoS One 8 e56124-11

[9] Cameron NE(2017)Pimpinella anisum L. ethanolic extract ameliorates the gentamicin-induced nephrotoxicity in rats Nephrology. 22 133-1075

[10] Dogné S(2016)Glycocalyx and its involvement in clinical pathophysiologies J Intensive Care 4 1-179